House oversight chair calls for investigation into PBMs' tactics to increase drug costs

In another effort to investigate pharma middlemen and their impact on healthcare costs, House Oversight Committee Chair James Comer (R-KY) is launching an investigation into pharmacy benefit managers’ (PBM) “tactics that are harming patient care and increasing costs for consumers.”